Skip to main content
. 2024 Sep 10;111(5):1005–1014. doi: 10.4269/ajtmh.24-0107

Figure 1.

Figure 1.

SAG2A seroprevalence by state in women of reproductive age (15–44 years)—Nigeria, 2018.